To present an opportunity that may meet our investment criteria, please provide a non-confidential summary for our consideration at info@bracepharma.com.
Our Investment Criteria
Therapy
Innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options
Development Phase
Clinical stage projects with potential to go to market in 3-5 years
Pre-clinical stage projects with predictive animal models and potential to go to market in 5-7 years
Development Strategy
High probability of technical and regulatory success with well defined, FDA validated, clinical efficacy endpoints
Orphan Drug Development
Preference for disease modifying treatments for debilitating orphan diseases
U.S. Market Potential
In excess of $200M revenue potential
Specialty Sales Force
Up to 100 representatives
Management
Highly experienced management team with an established track record of successful pharmaceutical development
Intellectual Property
Minimum of 7 year of patent life/market exclusivity